Vanderbilt University Medical Center (VUMC)
Playback speed
10 seconds
ASCO® 2023 Insights: "Phase 1b/2 Study of Batiraxcept (AVB-S6-500) as Monotherapy, in Combination With Cabo, and in Combination With Cabo & Nivo in Patients With Advanced/Metastatic ccRCC"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Katy Beckermann
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Katy Beckermann
130 views
June 6, 2023
Login to view comments.
Click here to Login